# Ethiopia Antimalarial in Vivo Efficacy Study 2012

> **NCT01680406** · PHASE4 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 398 (actual)

## Conditions studied

- Plasmodium Vivax Infection

## Interventions

- **DRUG:** Artemether-lumefantrine combination
- **DRUG:** Primaquine
- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT01680406
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 398 (ACTUAL)
- **Last updated:** 2017-01-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01680406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01680406, "Ethiopia Antimalarial in Vivo Efficacy Study 2012". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01680406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*